In Vitro Diagnostics Market are expected to expand at a 3% CAGR from 2022 to 2032 | FMI
During the forecast period, sales of In-Vitro Diagnostics are expected to expand at a 3% CAGR from 2022 to 2032, reaching a valuation of US$ 113 billion by 2026, up from US$ 98.2 billion in 2021. This efficient shift from a centralized to a point-of-care testing system is expected to drive the demand for in-vitro diagnostics forward. The Covid-19 pandemic impacted the in-vitro diagnostics market as the market faced challenges such as interrupted supply chains, inconsistent demand for products, and others. To learn more about this report @ https://www.futuremarketinsights.com/reports/in-vitro-diagnostics-market In addition, the availability of raw materials and human resources was severely impacted by the global pandemic. An increasing demand for in vitro diagnostics was witnessed during the pandemic era demanding new Covid-19 testing kits, which is serving as a huge opportunity for the key players in the IVD market. Therefore, the overall impact of the Covid-19 pa...